Leukemic Presentation of ALK-negative Anaplastic Large Cell Lymphoma in a Patient with Myelodysplastic Syndrome

被引：5

作者：

Tanaka, Hiroaki ^{[2
]}

Ohwada, Chikako ^{[1
]}

Hashimoto, Shinichiro ^{[2
]}

Sakai, Shio ^{[1
]}

Takeda, Yusuke ^{[1
]}

Abe, Daijiro ^{[1
]}

Takagi, Toshiyuki ^{[3
]}

Ohshima, Koichi ^{[4
]}

Nakaseko, Chiaki ^{[1
]}

机构：

[1] Chiba Univ Hosp, Dept Hematol, Chiba, Japan

[2] Oami Hosp, Dept Hematol, Oamishirasato, Japan

[3] Chiba Canc Ctr Hosp, Div Hematol Oncol, Chiba, Japan

[4] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan

来源：

INTERNAL MEDICINE | 2012年 / 51卷 / 02期

关键词：

anaplastic large cell lymphoma (ALCL); ALK-negative; leukemic manifestation; myelodysplastic syndrome; NON-HODGKIN-LYMPHOMA; PERIPHERAL-BLOOD; TRANSLOCATION; INVOLVEMENT; EXPRESSION; DISEASE; PHASE;

D O I：

10.2169/internalmedicine.51.6146

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 50-year-old woman with a history of aplastic anemia developed cervical lymphadenopathy and atypical lymphocytosis. Atypical cells of lymph nodes were positive for CD3 and CD30 but negative for anaplastic lymphoma kinase (ALK). Bone marrow examination showed trilineage myelodysplasia. She was diagnosed with ALK-negative anaplastic large cell lymphoma (ALCL) with leukemic transformation and myelodysplastic syndrome (MDS) which presumably developed from aplastic anemia. The lymphoma was resistant to intensive chemotherapies, ultimately leading to death. Leukemic presentation of ALK-negative ALCL as an initial manifestation is extremely rare, and the progression of the disease may be influenced by MDS through alteration of immune functions.

引用

页码：199 / 203

页数：5

共 50 条

[1] Leukemic presentation of a highly aggressive ALK-negative anaplastic large cell lymphoma
Xu, Danmei
Naresh, Kikkeri N.
BLOOD, 2021, 138 (13) : 1198 - 1198
[2] Anaplastic large cell lymphoma, ALK-negative
Ferreri, Andres J. M.
Govi, Silvia
Pileri, Stefano A.
Savage, Kerry J.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (02) : 206 - 215
[3] Granulomatous Inflammation in a Patient with ALK-Negative Anaplastic Large Cell Lymphoma
Alibakan, Ozlem Kandemir
Keskin, Gulsah
Yilmaz, Ugur
Arman, Yucel
Dogan, Esma Evrim
Arikan, Evsen Apaydin
TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (01) : 82 - 83
[4] Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma
Lourdes, Laura S.
Al-Quran, Samer Z.
Dang, Nam H.
Markham, Merry-Jennifer
CASE REPORTS IN HEMATOLOGY, 2012, 2012
[5] Pathobiology of ALK-negative anaplastic large cell lymphoma
Pileri, Stefano A.
Agostinelli, Claudio
Bacci, Francesco
Sabattini, Elena
Sagramoso, Carlo
Falini, Brunangelo
Piccaluga, Pier Paolo
PEDIATRIC REPORTS, 2011, 3 : 8 - 10
[6] ALK-negative anaplastic large-cell lymphoma
Gaulard, Philippe
de Leval, Laurence
BLOOD, 2016, 127 (02) : 175 - +
[7] ALK-negative anaplastic large cell lymphoma in leukemic phase with near-pentaploidy
Wong, W. S.
Liu, Brenda W. F.
Lam, Frankie S. C.
Wong, K. F.
LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1927 - 1930
[8] Leukemic phase of ALK-negative anaplastic large cell lymphoma in a patient who is on androgenic steroids: A case report
Kasinathan, Ganesh
ANNALS OF MEDICINE AND SURGERY, 2020, 49 : 1 - 4
[9] Primary CNS ALK-negative Anaplastic Large Cell Lymphoma
Brady, Amy
Hall, Walter
Banki, Katalin
Fuller, Christine
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 492 - 493
[10] Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
Satou, Akira
Feldman, Andrew L.
ACADEMIC PATHOLOGY, 2020, 7

← 1 2 3 4 5 →